You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Carmustine

Showing 26 - 50 of 275
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Glioblastoma, Gliosarcoma Trial in Seattle (radiation, procedure, drug, biological, other)

Completed
Has Results
  • Glioblastoma
  • Gliosarcoma
  • 3-Dimensional Conformal Radiation Therapy
  • +10 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Mar 4, 2022

Recurrent Hodgkin Lymphoma, Refractory Hodgkin Lymphoma Trial in Duarte (Basiliximab, Carmustine, Cytarabine)

Recruiting
  • Recurrent Hodgkin Lymphoma
  • Refractory Hodgkin Lymphoma
  • Basiliximab
  • +6 more
  • Duarte, California
    City of Hope Medical Center
Jun 16, 2022

Diffuse Large Cell Lymphoma, Lymphoma Trial in Houston (Zevalin, Carmustine, Etoposide)

Completed
Has Results
  • Diffuse Large Cell Lymphoma
  • Lymphoma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jan 12, 2021

Glioma Trial in Sacramento (bevacizumab, carmustine)

Completed
Has Results
  • Glioma
  • Sacramento, California
    University of California Davis Cancer Center
May 4, 2020

Glioblastoma Multiforme Trial in Canada, United States (drug, radiation, device)

Recruiting
  • Glioblastoma Multiforme
  • Birmingham, Alabama
  • +17 more
Apr 1, 2022

Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma Trial in New York (Bendamustine, Carmustine, Etoposide)

Completed
Has Results
  • Hodgkin's Lymphoma
  • Non-Hodgkin's Lymphoma
  • New York, New York
    Weill Cornell Medical College
Feb 1, 2021

Lymphoma Trial in Minneapolis (drug, procedure, radiation, biological)

Completed
Has Results
  • Lymphoma
  • carmustine
  • +6 more
  • Minneapolis, Minnesota
    Masonic Cancer Center at University of Minnesota
Jul 10, 2020

HIV Infection, Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma, Plasmablastic Lymphoma Trial in United States (procedure, drug,

Recruiting
  • HIV Infection
  • +10 more
  • Autologous Hematopoietic Stem Cell Transplantation
  • +7 more
  • La Jolla, California
  • +3 more
Dec 7, 2022

Diffuse Large B-cell Lymphoma (DLBCL), Relapsed Diffuse Large B-cell Lymphoma (DLBCL), Refractory Diffuse Large B-cell Lymphoma

Recruiting
  • Diffuse Large B-cell Lymphoma (DLBCL)
  • +2 more
  • leukapheresis
  • +3 more
  • Omaha, Nebraska
  • +13 more
Jan 21, 2022

Mantle Cell Lymphoma Trial in France (Obinutuzumab, Dexamethasone, Aracytine)

Active, not recruiting
  • Mantle Cell Lymphoma
  • Amiens, France
  • +29 more
Sep 14, 2021

Lymphoma, Leukemia Trial in Houston (drug, other, radiation, procedure)

Completed
Has Results
  • Lymphoma
  • Leukemia
  • Houston, Texas
    UT MD Anderson Cancer Center
Sep 1, 2020

Mantle Cell Lymphoma, Recurrent DLBCL, Recurrent Follicular Lymphoma Trial in Houston (procedure, drug, biological)

Completed
  • Mantle Cell Lymphoma
  • +6 more
  • Autologous Hematopoietic Stem Cell Transplantation
  • +8 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 18, 2022

Lymphoma, B-cell Lymphoma Trial in Houston (Leukapheresis, Stem Cell Transplant, CD19-specific T Cell Infusion)

Completed
  • Lymphoma
  • B-cell Lymphoma
  • Leukapheresis
  • +7 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jun 27, 2020

Glioblastoma Multiforme Trial in Cincinnati (BCNU Wafer, Irinotecan, Bevacizumab)

Withdrawn
  • Glioblastoma Multiforme
  • BCNU Wafer
  • +2 more
  • Cincinnati, Ohio
    University of Cincinnati
Nov 21, 2019

Lymphoma, Lymphoma, B-Cell, Lymphoma, T-Cell Trial in New York (Pharmacokinetics)

Recruiting
  • Lymphoma
  • +4 more
  • Pharmacokinetics
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Sep 12, 2022

Glioma, Glioblastoma Multiforme, Astrocytoma Trial (Conventional RT, Hyperfractionated RT, Carmustine)

Completed
  • Glioma
  • +2 more
  • Conventional RT
  • +2 more
  • (no location specified)
Nov 7, 2019

Peripheral T-Cell Lymphoma Trial in Saint Louis (Gemcitabine, Navelbine, Doxorubicin Hydrochloride Liposome Injection)

Terminated
Has Results
  • Peripheral T-Cell Lymphoma
  • Saint Louis, Missouri
    Washington University
Apr 14, 2020

Triple-Negative Invasive Breast Carcinoma, Residual Tumor Trial in Mexico City (Carmustine, Cyclophosphamide, Carboplatin)

Unknown status
  • Triple-Negative Invasive Breast Carcinoma
  • Residual Tumor
  • Carmustine
  • +4 more
  • Mexico City, Distrito Federal, Mexico
    Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubi
Jan 10, 2020

Prostate Cancer Trial in Baltimore (biological, drug, procedure)

Completed
  • Prostate Cancer
  • filgrastim
  • +5 more
  • Baltimore, Maryland
    Marlene & Stewart Greenebaum Cancer Center, University of Maryla
Oct 31, 2019

Lymphoma Trial in Canada, United States (biological, drug, procedure, radiation)

Completed
Has Results
  • Lymphoma
  • rituximab
  • +10 more
  • Portland, Oregon
  • +14 more
Jan 29, 2021

Leukemia Trial in Baltimore (biological, drug, procedure)

Completed
  • Leukemia
  • filgrastim
  • +10 more
  • Baltimore, Maryland
    Greenebaum Cancer Center at University of Maryland Medical Cente
Oct 31, 2019

Multiple Myeloma and Plasma Cell Tumor Trial in Baltimore (carmustine, cisplatin, cyclophosphamide)

Completed
  • Multiple Myeloma and Plasma Cell Neoplasm
  • carmustine
  • +7 more
  • Baltimore, Maryland
    Marlene & Stewart Greenebaum Cancer Center, University of Maryla
Oct 15, 2019

Ovarian Cancer Trial in Baltimore (biological, drug, procedure)

Completed
  • Ovarian Cancer
  • filgrastim
  • +6 more
  • Baltimore, Maryland
    Marlene & Stewart Greenebaum Cancer Center, University of Maryla
Oct 15, 2019

Lymphoma, Autologous Hematopoietic Stem Cell Transplantation Trial in Xi'an (Improved BEAM regimen)

Not yet recruiting
  • Lymphoma
  • Autologous Hematopoietic Stem Cell Transplantation
  • Improved BEAM regimen
  • Xi'an, Shaanxi, China
    First Affiliated Hospital of Xi'an Jiaotong University
Dec 26, 2022

Frontline of ASCT in High-risk DLBCL

Recruiting
  • Diffuse Large B Cell Lymphoma
    • Beijing, Beijing, China
      Peking University People's Hospital
    Apr 26, 2023